Advertisement

Higher non-cardiac mortality and lesser impact of early revascularization in patients with type 2 compared to type 1 acute myocardial infarction: results from the Tokyo CCU Network registry

  • Satoshi HiguchiEmail author
  • Makoto Suzuki
  • Yu Horiuchi
  • Hiroyuki Tanaka
  • Mike Saji
  • Hideaki Yoshino
  • Ken Nagao
  • Takeshi Yamamoto
  • Morimasa Takayama
Original Article
  • 19 Downloads

Abstract

As the definition of type 2 acute myocardial infarction (AMI) is obscure, the characteristics of this disease vary among studies. The clinical significance of type 2 AMI is unclear. We surveyed the Tokyo Cardiovascular Care Unit (CCU) Network registry between 2010 and 2014. The difference in clinical characteristics and the impact of revascularization in patients with type 1 and type 2 AMI were evaluated. The cohort study included 12514 patients admitted to CCU (type 1 AMI, 12023; type 2 AMI, 491; mean age, 68 ± 15 years; 75% male). Coronary angiography was performed in 11402 patients (95%) with type 1 AMI and 427 (87%) with type 2 AMI (p < 0.001). Type 2 AMI was associated with higher in-hospital mortality (type 1 AMI, 769 (6.4%); type 2 AMI, 54 (11.0%); adjusted odds ratio (OR) 1.64; 95% confidence interval (CI) 1.12–2.41; p = 0.011) and higher non-cardiac mortality (adjusted OR 2.19; 95% CI 1.33–3.62; p = 0.002), but similar cardiac mortality rate compared to type 1 AMI (adjusted OR 1.17; 95% CI 0.71–1.91; p = 0.539). Percutaneous coronary intervention (PCI) within 24 h after the onset was associated with lower in-hospital mortality in those with type 1 AMI (OR 0.47; 95% CI 0.40–0.55; p < 0.001), but not in those with type 2 AMI (OR 1.09; 95% CI 0.62–1.94; p = 0.763). The results persisted after adjustment for multivariate logistic regression analysis and inverted probability weighting. In conclusion, patients with type 2 AMI had higher in-hospital mortality owing to higher non-cardiac death. More refined definitions focusing on the treatment of comorbidities may be required, as the treatment strategy for type 2 AMI can be different from that for type 1 AMI.

Keywords

Type 2 AMI Acute myocardial infarction Universal definition of myocardial infarction Non-cardiac mortality Percutaneous coronary intervention 

Notes

Acknowledgements

Financial support for this study was provided by the Tokyo Metropolitan Government, and JSPS KAKENHI Grant number 17K18085 [S.H.]. We thank all the cardiologists and staff participating in the Tokyo CCU Network and Ms. Nobuko Yoshida (Tokyo CCU Network office) for data acquisition.

Compliance withe ethical standards

Conflict of interest

The authors report no conflicts of interest.

References

  1. 1.
    Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N (2007) Universal definition of myocardial infarction. Circulation 116:2634–2653CrossRefGoogle Scholar
  2. 2.
    Nestelberger T, Boeddinghaus J, Mueller C (2018) Type 2 myocardial infarction. Eur Heart J 39:3825CrossRefGoogle Scholar
  3. 3.
    Melberg T, Burman R, Dickstein K (2010) The impact of the 2007 ESC-ACC-AHA-WHF universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol 139:228–233CrossRefGoogle Scholar
  4. 4.
    Javed U, Aftab W, Ambrose JA, Wessel RJ, Mouanoutoua M, Huang G, Barua RS, Weilert M, Sy F, Thatai D (2009) Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 104:9–13CrossRefGoogle Scholar
  5. 5.
    Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, Hallas J, Thygesen K, Mickley H (2013) Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 126:789–797CrossRefGoogle Scholar
  6. 6.
    Collinson P, Lindahl B (2015) Type 2 myocardial infarction: the chimaera of cardiology? Heart 101:1697–1703CrossRefGoogle Scholar
  7. 7.
    Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRefGoogle Scholar
  8. 8.
    Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD (2018) Fourth universal definition of myocardial infarction (2018). Eur Heart J.  https://doi.org/10.1093/eurheartj/ehy462 Google Scholar
  9. 9.
    Roffi M, Radovanovic D, Iglesias JF, Eberli FR, Urban P, Pedrazzini GB, Erne P, Rickli H (2018) Multisite vascular disease in acute coronary syndromes: increased in-hospital mortality and no improvement over time. Eur Heart J Acute Cardiovasc Care.  https://doi.org/10.1177/2048872618814708 Google Scholar
  10. 10.
    Stein GY, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D, Gevrielov-Yusim N, Iakobishvili Z, Fuchs S (2014) Type-II myocardial infarction–patient characteristics, management and outcomes. PLoS One 9:e84285CrossRefGoogle Scholar
  11. 11.
    Lopez-Cuenca A, Gomez-Molina M, Flores-Blanco PJ, Sanchez-Martinez M, Garcia-Narbon A, De Las Heras-Gomez I, Sanchez-Galian MJ, Guerrero-Perez E, Valdes M, Manzano-Fernandez S (2016) Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes. J Geriatr Cardiol 13:15–22Google Scholar
  12. 12.
    Baron T, Hambraeus K, Sundstrom J, Erlinge D, Jernberg T, Lindahl B (2015) Type 2 myocardial infarction in clinical practice. Heart 101:101–106CrossRefGoogle Scholar
  13. 13.
    Gupta S, Vaidya SR, Arora S, Bahekar A, Devarapally SR (2017) Type 2 versus type 1 myocardial infarction: a comparison of clinical characteristics and outcomes with a meta-analysis of observational studies. Cardiovasc Diagn Ther 7:348–358CrossRefGoogle Scholar
  14. 14.
    Sarkisian L, Saaby L, Poulsen TS, Gerke O, Jangaard N, Hosbond S, Diederichsen AC, Thygesen K, Mickley H (2016) Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med 129(4):446.e5–446.e21CrossRefGoogle Scholar
  15. 15.
    Neumann JT, Sorensen NA, Rubsamen N, Ojeda F, Renne T, Qaderi V, Teltrop E, Kramer S, Quantius L, Zeller T, Karakas M, Blankenberg S, Westermann D (2017) Discrimination of patients with type 2 myocardial infarction. Eur Heart J 38:3514–3520CrossRefGoogle Scholar
  16. 16.
    Baron T, Hambraeus K, Sundstrom J, Erlinge D, Jernberg T, Lindahl B (2016) Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction. Am J Med 129:398–406CrossRefGoogle Scholar
  17. 17.
    Ambrose JA, Loures-Vale A, Javed U, Buhari CF, Aftab W (2012) Angiographic correlates in type 1 and 2 MI by the universal definition. JACC Cardiovasc Imaging 5:463–464CrossRefGoogle Scholar
  18. 18.
    Kusama Y, Kodani E, Nakagomi A, Otsuka T, Atarashi H, Kishida H, Mizuno K (2011) Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. J Nippon Med Sch 78:4–12CrossRefGoogle Scholar
  19. 19.
    Adamson PD, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Mills NL (2018) Cardiac troponin I and cardiovascular risk in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 72:1126–1137CrossRefGoogle Scholar
  20. 20.
    Hritani AW, Jan MF, Schleis G, Zehrer T, Olet S, Ammar KA, Allaqaband S (2018) Clinical features and prognosis of type 2 myocardial infarction in acutely decompensated diabetic patients. Am J Med 131:820–828CrossRefGoogle Scholar
  21. 21.
    McCarthy CP, Vaduganathan M, Januzzi JL Jr (2018) Type 2 myocardial infarction-diagnosis, prognosis, and treatment. JAMA 320(5):433–434CrossRefGoogle Scholar
  22. 22.
    Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Wildi K, Breitenbucher D, Sabti Z, Puelacher C, Rubini Gimenez M, Kozhuharov N, Strebel I, Sazgary L, Schneider D, Jann J, du Fay de Lavallaz J, Miro O, Martin-Sanchez FJ, Morawiec B, Kawecki D, Muzyk P, Keller DI, Geigy N, Osswald S, Reichlin T, Mueller C (2017) Effect of definition on incidence and prognosis of type 2 myocardial infarction. J Am Coll Cardiol 70:1558–1568CrossRefGoogle Scholar
  23. 23.
    Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, McAllister DA, Strachan FE, Newby DE, Mills NL (2018) Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation 137:1236–1245CrossRefGoogle Scholar
  24. 24.
    McCarthy CP, Vaduganathan M, Singh A, Song Z, Blankstein R, Gaggin HK, Wasfy JH, Januzzi JL Jr (2018) Type 2 myocardial infarction and the hospital readmission reduction program. J Am Coll Cardiol 72:1166–1170CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Tokyo CCU Network Scientific CommitteeTokyoJapan
  2. 2.Department of CardiologyKyorin University HospitalMitakaJapan

Personalised recommendations